Related Experiment Video
Updated: Jun 1, 2026
10:03
Inducing Meningococcal Meningitis Serogroup C in Mice via Intracisternal Delivery
Published on: November 5, 2019
New frontiers in meningococcal vaccines
Annaliesa S Anderson1, Kathrin U Jansen, Joseph Eiden
1Pfizer Vaccine Research, Pearl River, NY 10965, USA. annaliesa.anderson@pfizer.com
Expert Review of Vaccines
|May 25, 2011
Summary
Developing effective meningococcal vaccines and vaccination programs faces ongoing challenges. Continuous monitoring and strategic vaccine development are crucial for broad protection and eradicating meningococcal disease globally.
Area of Science:
- Immunology
- Vaccinology
- Public Health
Background:
- Meningococcal disease remains a significant global health threat, necessitating effective vaccines and vaccination programs.
- Current vaccination strategies aim for broad strain coverage and herd immunity, but challenges persist.
Purpose of the Study:
- To review the challenges and successes in developing and implementing meningococcal vaccines and vaccination programs.
- To highlight the need for continuous monitoring of vaccine effectiveness and disease epidemiology.
Main Methods:
- Review of existing literature on meningococcal vaccines and vaccination programs.
- Analysis of epidemiological data and vaccine impact studies.
Main Results:
- Meningococcal serogroup C conjugate vaccines have shown significant public health impact.
- Challenges remain in deploying serogroup A vaccines in developing countries and developing broadly protective serogroup B vaccines.
Conclusions:
- Continuous monitoring of vaccination program effectiveness and disease epidemiology is essential.
- Addressing current vaccine development and implementation challenges is key to controlling meningococcal disease worldwide.
Related Concept Videos
01:22Bacterial Meningitis I: Introduction
Bacterial meningitis is a severe, life-threatening inflammation of the meninges, particularly the pia mater and arachnoid mater, affecting the subarachnoid space, ventricles, and cerebrospinal fluid (CSF). If untreated, it can lead to significant neurological complications or death.Causative AgentsCommon pathogens vary with age and immune status. In adults, major organisms include Streptococcus pneumoniae, Neisseria meningitidis, and Haemophilus influenzae. Streptococcus agalactiae (group B...
01:24Bacterial Meningitis
Bacterial meningitis is a severe infectious disease involving inflammation of the meninges, the protective membranes surrounding the brain and spinal cord. It occurs when pathogenic bacteria cross the blood–brain barrier and enter the cerebrospinal fluid. Common causative organisms include Neisseria meningitidis, Streptococcus pneumoniae, Haemophilus influenzae type b, Listeria monocytogenes, and Escherichia coli K1. The exact route of entry varies by pathogen and host condition.Routes of Entry...
01:26Bacterial Meningitis II: Pathophysiology
Bacterial meningitis typically begins when pathogens such as Neisseria meningitidis and Streptococcus pneumoniae colonize the nasopharynx and invade the bloodstream. This process is facilitated by bacterial virulence factors, such as polysaccharide capsules, which resist phagocytosis and complement-mediated killing. Less commonly, bacteria reach the central nervous system via contiguous spread from infections like otitis media or sinusitis, through congenital or acquired dural defects, or...
01:27Cryptococcal Meningitis
Cryptococcal meningitis is a life-threatening opportunistic infection predominantly associated with HIV/AIDS, accounting for over 100,000 deaths annually worldwide. However, it also affects individuals with other forms of immunosuppression, including those undergoing immunosuppressive therapy, organ transplant recipients, patients with innate immunodeficiencies, and individuals with hematological disorders. The infection is caused mainly by Cryptococcus neoformans and Cryptococcus gattii,...
01:18Viral Meningitis
Viral meningitis is the most common form of meningitis and is often referred to as aseptic meningitis to indicate the absence of bacterial involvement. It is generally milder than bacterial meningitis, with symptoms including fever, headache, stiff neck, drowsiness, nausea, photophobia, and vomiting. Rarely, more severe manifestations or death may occur. Common causative agents include enteroviruses, particularly coxsackie A and B viruses and echoviruses, all members of the Enterovirus genus...
01:29Microorganisms in Medicine and Therapeutics
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.